ConductScience.org, home

Paper803231

Intravenous nitroglycerin in acute myocardial infarction.

Flaherty JT and 5 others. Circulation, 1975. Cited by 343 papers, by iCite.

Cite this record

ConductScience Library. Intravenous nitroglycerin in acute myocardial infarction. Papers, record 803231. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/803231

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intravenous nitroglycerin in acute myocardial infarction.
PubMed
Journal
Circulation
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
343
iCite
Relative citation ratio, by iCite
15.5
iCite
Revised in PubMed
2019-06-23
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Flaherty JTJ T
2Reid PRP R
3Kelly DTD T
4Taylor DRD R
5Weisfeldt MLM L
6Pitt BB

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
Myocardial InfarctionMajor topic
NitroglycerinMajor topic
Administration, Oral
Adult
Aged
Blood Pressure
Cardiac Output
Drug Evaluation
Female
Heart Rate
Humans
Infusions, Parenteral
Male
Middle Aged
Time Factors
Vascular Resistance

Source PubMed

Download CSV of topics

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 343 citations.

PMIDTitleJournalYearIn PapersSource
39443402Hydrogel encapsulating gold nanoparticles for targeted delivery of nitroglycerin to reduce post-cardiac dysfunction inflammation by inhibiting the Wnt/β-catenin signaling pathway.Inflammopharmacology2024https://conductscience.org/library/papers/39443402PubMed
35424754Methyl nitrate energetic compounds based on bicyclic scaffolds of furazan-isofurazan (isoxazole): syntheses, crystal structures and detonation performances.RSC Adv2022https://conductscience.org/library/papers/35424754PubMed
29489681A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study.Medicine (Baltimore)2018https://conductscience.org/library/papers/29489681PubMed
26052226Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering.Biomark Insights2015https://conductscience.org/library/papers/26052226PubMed
24936244Short acting insulin analogues in intensive care unit patients.World J Diabetes2014https://conductscience.org/library/papers/24936244PubMed
24102516Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives.J Med Chem2013https://conductscience.org/library/papers/24102516PubMed
8934953Induced hypotension during anesthesia with special reference to orthognathic surgery.Anesth Prog1995https://conductscience.org/library/papers/8934953PubMed
8113155Use of nitroglycerin for the treatment of acute myocardial infarction.Heart Vessels1994https://conductscience.org/library/papers/8113155PubMed
7848898Nitrates in myocardial infarction.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7848898PubMed
7470340Variability of electrocardiographic and enzyme evolution of myocardial infarction in man.Br Heart J1981https://conductscience.org/library/papers/7470340PubMed
7441784Reduction of myocardial ischemic injury with sublingual isosorbide dinitrate.J Natl Med Assoc1980https://conductscience.org/library/papers/7441784PubMed
7378211Salbutamol in cardiogenic shock complicating acute myocardial infarction.Br Heart J1980https://conductscience.org/library/papers/7378211PubMed
6994708The effect of single and repeated oral doses of isosorbide dinitrate on plasma renin activity and plasma catecholamine levels in conscious dogs.Basic Res Cardiol1980https://conductscience.org/library/papers/6994708PubMed
6804554Intravenous nitroglycerin perfusion techniques--clinical implications.Intensive Care Med1982https://conductscience.org/library/papers/6804554PubMed
6804202Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use.Drugs1982https://conductscience.org/library/papers/6804202PubMed
6429221The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure.Intensive Care Med1984https://conductscience.org/library/papers/6429221PubMed
6420139Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.Drugs1984https://conductscience.org/library/papers/6420139PubMed
6408300[Possible evidence for a reduction of early and late mortality during nitroglycerin therapy in acute myocardial infarction].Klin Wochenschr1983https://conductscience.org/library/papers/6408300PubMed
6404289Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised study.Br Heart J1983https://conductscience.org/library/papers/6404289PubMed
6403603Vasodilators in acute circulatory failure.Intensive Care Med1983https://conductscience.org/library/papers/6403603PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/803231

GET https://conductscience.org/api/papers/v1/803231/cited_by?page=2